On Monday, Rani Therapeutics Holdings Inc (NASDAQ: RANI) was 8.21% up from the session before settling in for the closing price of $1.34. A 52-week range for RANI has been $0.39 – $3.87.
Healthcare Sector giant saw their annual sales surged by 4.78% over the last five years. When this article was written, the company’s average yearly earnings per share was at 59.52%. With a float of $60.42 million, this company’s outstanding shares have now reached $97.55 million.
Rani Therapeutics Holdings Inc (RANI) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Rani Therapeutics Holdings Inc stocks. The insider ownership of Rani Therapeutics Holdings Inc is 38.07%, while institutional ownership is 12.13%. The most recent insider transaction that took place on Oct 23 ’25, was worth 1,260,417. In this transaction Director of this company bought 2,083,334 shares at a rate of $0.60, taking the stock ownership to the 2,083,334 shares. Before that another transaction happened on Oct 21 ’25, when Company’s 10% Owner sold 4,000,000 for $2.77, making the entire transaction worth $11,074,000. This insider now owns 2,379,194 shares in total.
Rani Therapeutics Holdings Inc (RANI) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.16 earnings per share (EPS) during the time that was better than consensus figure (set at -0.23) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 59.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.44% during the next five years compared to 4.78% growth over the previous five years of trading.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Trading Performance Indicators
You can see what Rani Therapeutics Holdings Inc (RANI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 146.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Rani Therapeutics Holdings Inc (RANI)
Analysing the last 5-days average volume posted by the [Rani Therapeutics Holdings Inc, RANI], we can find that recorded value of 2.56 million was lower than the volume posted last year of 5.64 million. As of the previous 9 days, the stock’s Stochastic %D was 42.86%.
During the past 100 days, Rani Therapeutics Holdings Inc’s (RANI) raw stochastic average was set at 29.44%, which indicates a significant decrease from 32.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1349 in the past 14 days, which was lower than the 0.1653 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5844, while its 200-day Moving Average is $0.9778. Now, the first resistance to watch is $1.5000. This is followed by the second major resistance level at $1.5500. The third major resistance level sits at $1.6200. If the price goes on to break the first support level at $1.3800, it is likely to go to the next support level at $1.3100. Now, if the price goes above the second support level, the third support stands at $1.2600.
Rani Therapeutics Holdings Inc (NASDAQ: RANI) Key Stats
There are 121,512K outstanding shares of the company, which has a market capitalization of 176.21 million. As of now, sales total 1,030 K while income totals -30,020 K. Its latest quarter income was 0 K while its last quarter net income were -6,690 K.
